SGLT-2 Revisited: Diabetes Management in Chronic Kidney Disease

31/5/2021

Annals On Call Podcast

0:00

34:03

Dr. Centor discusses the management of patients with diabetes and kidney disease with Drs. Katherine Tuttle and Jonathan Himmelfarb.

Altri episodi di "Annals On Call Podcast"

Complications Associated With Transvenous Cardiac Implantable Devices
2 giorni fa
25:18
Dr. Centor discusses complications of cardiac implantable electronic devices with Dr. Peter Zimetbaum.
Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis
1/12/2025
25:17
Dr. Centor discusses the use of weight loss drugs to treat patients with knee osteoarthritis with Dr. David Felson.
Non perdere nemmeno un episodio di “Annals On Call Podcast”. Iscriviti all'app gratuita GetPodcast.
Palliative Care: A Family Perspective
17/11/2025
19:37
Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.
What You May Have Missed in 2024: Part 3
3/11/2025
15:33
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
What You May Have Missed in 2024 - Part 2
20/10/2025
13:52
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
High-Concentration Cannabinoids: Are They Safe?
6/10/2025
29:05
Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
What You May Have Missed in 2024: Part 1
15/9/2025
20:13
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Fibrillation - When Ablation is the Way to Go
1/9/2025
22:36
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
18/8/2025
29:55
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
4/8/2025
21:11
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.

Altri episodi

Accedi a tutto il mondo dei podcast con l’app gratuita GetPodcast.

Iscriviti ai tuoi podcast preferiti, ascolta gli episodi offline e ricevi fantastici consigli.

SGLT-2 Revisited: Diabetes Management in Chronic Kidney Disease

Annals On Call Podcast

Altri episodi di "Annals On Call Podcast"

Complications Associated With Transvenous Cardiac Implantable Devices

Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis

Palliative Care: A Family Perspective

What You May Have Missed in 2024: Part 3

What You May Have Missed in 2024 - Part 2

High-Concentration Cannabinoids: Are They Safe?

What You May Have Missed in 2024: Part 1

Fibrillation - When Ablation is the Way to Go

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide